Literature DB >> 20201022

New insights into the nature of autoinflammatory diseases from mice with Nlrp3 mutations.

Guangxun Meng1, Warren Strober.   

Abstract

Mutations in the Nlrp3 (CIAS1, cryopyrin) gene are associated with cryopyrin-associated periodic syndrome, autoinflammatory diseases characterized by excessive IL-1 production and neutrophilia in blood and tissues. Recent studies with gene-targeted mice expressing mutations homologous to those found in cryopyrin-associated periodic syndrome patients have advanced the understanding of NLRP3-associated autoinflammation. In this Viewpoint, we will discuss the mechanisms of NLRP3 inflammasome activation and its induction of Th17-cell-dominant immunologic responses.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20201022      PMCID: PMC3729261          DOI: 10.1002/eji.200940191

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  35 in total

1.  Activated STAT4 has an essential role in Th1 differentiation and proliferation that is independent of its role in the maintenance of IL-12R beta 2 chain expression and signaling.

Authors:  Ryuta Nishikomori; Takashi Usui; Chang-Yu Wu; Akio Morinobu; John J O'Shea; Warren Strober
Journal:  J Immunol       Date:  2002-10-15       Impact factor: 5.422

2.  Cross-talk between interleukin 1beta (IL-1beta) and IL-6 signalling pathways: IL-1beta selectively inhibits IL-6-activated signal transducer and activator of transcription factor 1 (STAT1) by a proteasome-dependent mechanism.

Authors:  X Shen; Z Tian; M J Holtzman; B Gao
Journal:  Biochem J       Date:  2000-12-15       Impact factor: 3.857

3.  Interleukin-1 beta maturation and release in response to ATP and nigericin. Evidence that potassium depletion mediated by these agents is a necessary and common feature of their activity.

Authors:  D Perregaux; C A Gabel
Journal:  J Biol Chem       Date:  1994-05-27       Impact factor: 5.157

4.  Use of canakinumab in the cryopyrin-associated periodic syndrome.

Authors:  Helen J Lachmann; Isabelle Kone-Paut; Jasmin B Kuemmerle-Deschner; Kieron S Leslie; Eric Hachulla; Pierre Quartier; Xavier Gitton; Albert Widmer; Neha Patel; Philip N Hawkins
Journal:  N Engl J Med       Date:  2009-06-04       Impact factor: 91.245

5.  Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf.

Authors:  Sanjeev Mariathasan; Kim Newton; Denise M Monack; Domagoj Vucic; Dorothy M French; Wyne P Lee; Meron Roose-Girma; Sharon Erickson; Vishva M Dixit
Journal:  Nature       Date:  2004-06-09       Impact factor: 49.962

6.  Molecular basis of the spectral expression of CIAS1 mutations associated with phagocytic cell-mediated autoinflammatory disorders CINCA/NOMID, MWS, and FCU.

Authors:  Bénédicte Neven; Isabelle Callebaut; Anne-Marie Prieur; Jérôme Feldmann; Christine Bodemer; Loredana Lepore; Beata Derfalvi; Suata Benjaponpitak; Richard Vesely; Marie Jose Sauvain; Stefan Oertle; Roger Allen; Gareth Morgan; Arndt Borkhardt; Clare Hill; Janet Gardner-Medwin; Alain Fischer; Geneviève de Saint Basile
Journal:  Blood       Date:  2003-11-20       Impact factor: 22.113

7.  Inflammasome-mediated disease animal models reveal roles for innate but not adaptive immunity.

Authors:  Susannah D Brydges; James L Mueller; Matthew D McGeough; Carla A Pena; Amirhossein Misaghi; Chhavi Gandhi; Chris D Putnam; David L Boyle; Gary S Firestein; Anthony A Horner; Pejman Soroosh; Wendy T Watford; John J O'Shea; Daniel L Kastner; Hal M Hoffman
Journal:  Immunity       Date:  2009-06-04       Impact factor: 31.745

8.  A mutation in the Nlrp3 gene causing inflammasome hyperactivation potentiates Th17 cell-dominant immune responses.

Authors:  Guangxun Meng; Fuping Zhang; Ivan Fuss; Atsushi Kitani; Warren Strober
Journal:  Immunity       Date:  2009-06-04       Impact factor: 31.745

9.  Critical regulation of early Th17 cell differentiation by interleukin-1 signaling.

Authors:  Yeonseok Chung; Seon Hee Chang; Gustavo J Martinez; Xuexian O Yang; Roza Nurieva; Hong Soon Kang; Li Ma; Stephanie S Watowich; Anton M Jetten; Qiang Tian; Chen Dong
Journal:  Immunity       Date:  2009-04-09       Impact factor: 31.745

10.  The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA.

Authors:  Irving C Allen; Margaret A Scull; Chris B Moore; Eda K Holl; Erin McElvania-TeKippe; Debra J Taxman; Elizabeth H Guthrie; Raymond J Pickles; Jenny P-Y Ting
Journal:  Immunity       Date:  2009-04-09       Impact factor: 31.745

View more
  6 in total

1.  The NLRP3 inflammasome activation in human or mouse cells, sensitivity causes puzzle.

Authors:  Hongbin Wang; Liming Mao; Guangxun Meng
Journal:  Protein Cell       Date:  2013-08       Impact factor: 14.870

Review 2.  Periodic Fever syndromes.

Authors:  Zachary Jacobs; Christina E Ciaccio
Journal:  Curr Allergy Asthma Rep       Date:  2010-11       Impact factor: 4.806

3.  Pathogenic fungus Microsporum canis activates the NLRP3 inflammasome.

Authors:  Liming Mao; Liping Zhang; Hua Li; Wei Chen; Hongbin Wang; Shuxian Wu; Caiqin Guo; Ailing Lu; Guiwen Yang; Liguo An; Paride Abliz; Guangxun Meng
Journal:  Infect Immun       Date:  2013-12-09       Impact factor: 3.441

4.  HCV genomic RNA activates the NLRP3 inflammasome in human myeloid cells.

Authors:  Wei Chen; Yongfen Xu; Hua Li; Wanyin Tao; Yu Xiang; Bing Huang; Junqi Niu; Jin Zhong; Guangxun Meng
Journal:  PLoS One       Date:  2014-01-06       Impact factor: 3.240

Review 5.  ATP-Binding and Hydrolysis in Inflammasome Activation.

Authors:  Christina F Sandall; Bjoern K Ziehr; Justin A MacDonald
Journal:  Molecules       Date:  2020-10-07       Impact factor: 4.411

6.  Remodelling of the gut microbiota by hyperactive NLRP3 induces regulatory T cells to maintain homeostasis.

Authors:  Xiaomin Yao; Chenhong Zhang; Yue Xing; Guang Xue; Qianpeng Zhang; Fengwei Pan; Guojun Wu; Yingxin Hu; Qiuhong Guo; Ailing Lu; Xiaoming Zhang; Rongbin Zhou; Zhigang Tian; Benhua Zeng; Hong Wei; Warren Strober; Liping Zhao; Guangxun Meng
Journal:  Nat Commun       Date:  2017-12-01       Impact factor: 14.919

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.